[PDF][PDF] Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study

S Khaerunnisa, H Kurniawan, R Awaluddin, S Suhartati… - Preprints, 2020 - lavierebelle.org
COVID-19, a new strain of coronavirus (CoV), was identified in Wuhan, China, in 2019. No
specific therapies are available and investigations regarding COVID-19 treatment are …

[PDF][PDF] Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: an in silico strategy unveils a hope against CORONA

S Adem, V Eyupoglu, I Sarfraz, A Rasul, M Ali - Preprints, 2020 - academia.edu
COVID-19, a rapidly spreading new strain of coronavirus, has affected more than 150
countries and received worldwide attention. The lack of efficacious drugs or vaccines …

Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach

R Majumder, M Mandal - Journal of Biomolecular Structure and …, 2022 - Taylor & Francis
A new strain of coronavirus (CoV) has been identified as SARS-CoV-2, which is responsible
for the recent COVID-19 pandemic. Currently, there is no approved vaccine or drug …

Molecular docking and dynamics study to explore phytochemical ligand molecules against the main protease of SARS-CoV-2 from extensive phytochemical datasets

S Mahmud, MA Mita, S Biswas, GK Paul… - Expert Review of …, 2021 - Taylor & Francis
Background The high transmission and pathogenicity of SARS-CoV-2 has led to a pandemic
that has halted the world's economy and health. The newly evolved strains and scarcity of …

In silico identification of potent COVID-19 main protease inhibitors from FDA approved antiviral compounds and active phytochemicals through molecular docking: a …

V Chandel, S Raj, B Rathi, D Kumar - 2020 - preprints.org
The Novel Coronavirus (COVID-19) is a positive-sense single-stranded RNA ((+) ssRNA)
virus. The COVID-19 Main Proteases play very important role in the propagation of the Novel …

In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents of Calendula …

P Das, R Majumder, M Mandal… - Journal of Biomolecular …, 2021 - Taylor & Francis
The recent outbreak of the coronavirus disease COVID-19 is putting the world towards a
great threat. A recent study revealed COVID-19 main protease (Mpro) is responsible for the …

Virtual screening and molecular dynamics simulation study of plant-derived compounds to identify potential inhibitors of main protease from SARS-CoV-2

S Mahmud, MAR Uddin, GK Paul… - Briefings in …, 2021 - academic.oup.com
The new coronavirus (SARS-CoV-2) halts the world economy and caused unbearable
medical emergency due to high transmission rate and also no effective vaccine and drugs …

[HTML][HTML] Inhibitory effect of eight secondary metabolites from conventional medicinal plants on COVID_19 virus protease by molecular docking analysis

N Mohammadi, N Shaghaghi - 2020 - europepmc.org
Due to the reported high ability of virulence of COVID_19 in recent months, several studies
have been conducted to discover and introduce COVID_19 antiviral drugs. The results of …

In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach

D Kumar, V Chandel, S Raj, B Rathi - Chemical Biology Letters, 2020 - pubs.iscience.in
Abstract The Coronavirus COVID-19 Main Proteases play critical role in the propagation of
the Novel Coronavirus (COVID-19). We have applied a bioinformatics approach of drug …

Plant‐derived chemicals as potential inhibitors of SARS‐CoV‐2 main protease (6LU7), a virtual screening study

M Sisakht, A Mahmoodzadeh… - Phytotherapy …, 2021 - Wiley Online Library
SARS‐CoV‐2 has caused millions of infections and more than 700,000 deaths. Taking the
urgent need to find new therapeutics for coronavirus disease 2019 (COVID‐19), a dataset of …